OA10976A - Pharmaceutical compositions of corticotropin releasing hormone antagonists - Google Patents

Pharmaceutical compositions of corticotropin releasing hormone antagonists Download PDF

Info

Publication number
OA10976A
OA10976A OA9900034A OA9900034A OA10976A OA 10976 A OA10976 A OA 10976A OA 9900034 A OA9900034 A OA 9900034A OA 9900034 A OA9900034 A OA 9900034A OA 10976 A OA10976 A OA 10976A
Authority
OA
OAPI
Prior art keywords
dimethyl
phenoxy
ethyl
trimethyl
propoxy
Prior art date
Application number
OA9900034A
Other languages
English (en)
French (fr)
Inventor
Chen Yuhpyng Liang
Fossa Anthony Andrea
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA10976A publication Critical patent/OA10976A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA9900034A 1998-02-17 1999-02-16 Pharmaceutical compositions of corticotropin releasing hormone antagonists OA10976A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7493498P 1998-02-17 1998-02-17

Publications (1)

Publication Number Publication Date
OA10976A true OA10976A (en) 2001-11-05

Family

ID=22122537

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900034A OA10976A (en) 1998-02-17 1999-02-16 Pharmaceutical compositions of corticotropin releasing hormone antagonists

Country Status (28)

Country Link
US (1) US6043260A (is)
EP (1) EP0951906A1 (is)
JP (1) JPH11292766A (is)
KR (1) KR19990072616A (is)
CN (1) CN1231176A (is)
AP (1) AP9901464A0 (is)
AR (1) AR017723A1 (is)
AU (1) AU1732999A (is)
BG (1) BG103180A (is)
BR (1) BR9900653A (is)
CA (1) CA2262252C (is)
EA (1) EA199900124A3 (is)
GT (1) GT199900015A (is)
HR (1) HRP990054A2 (is)
HU (1) HUP9900386A3 (is)
ID (1) ID23218A (is)
IL (1) IL128531A0 (is)
IS (1) IS4975A (is)
MA (1) MA26608A1 (is)
NO (1) NO990722L (is)
OA (1) OA10976A (is)
PA (1) PA8467401A1 (is)
PE (1) PE20000266A1 (is)
PL (1) PL331507A1 (is)
SG (1) SG81261A1 (is)
TN (1) TNSN99024A1 (is)
TR (1) TR199900328A2 (is)
ZA (1) ZA991220B (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125880B1 (en) 1995-06-06 2006-10-24 Pfizer Inc. Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
AU7604400A (en) 1999-09-21 2001-04-24 Emory University Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
KR20020063934A (ko) * 2000-01-18 2002-08-07 화이자 프로덕츠 인코포레이티드 코르티코트로핀 방출 인자 길항제
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US6992087B2 (en) 2001-11-21 2006-01-31 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US7015229B2 (en) 2002-02-22 2006-03-21 Pfizer Inc Substituted pyrimidinones and pyrimidinthiones
AU2003220190A1 (en) * 2002-03-13 2003-09-29 Pharmacia & Upjohn Company Llc Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
JP2005533014A (ja) * 2002-04-26 2005-11-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 置換ピラジン誘導体
JP2006506350A (ja) * 2002-09-12 2006-02-23 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 置換１，４−ピラジン誘導体
AR041470A1 (es) * 2002-10-17 2005-05-18 Upjohn Co Compuestos de pirrolo (1,2 - b) piridazina y sus usos
EP1565454A1 (en) * 2002-11-21 2005-08-24 Pharmacia & Upjohn Company LLC Pyrazine compounds as crf modulators
BRPI0409649A (pt) * 2003-04-23 2006-04-25 Pharmacia & Upjohn Co Llc pirimidinonas e pirimidinotionas substituìdas como antagonistas de crf
MXPA05011993A (es) * 2003-05-07 2006-02-02 Pharmacia & Upjohn Co Llc Compuestos de pirrolo[1,2-b]piridazina.
EP1625125A1 (en) * 2003-05-09 2006-02-15 Pharmacia & Upjohn Company LLC Compounds as crf1 receptor antagonists
MXPA05012081A (es) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Co Llc Derivados de pirimidina sustituidos.
EP1626965A1 (en) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Company LLC Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
WO2005089639A2 (en) * 2004-03-16 2005-09-29 Talarico M D Matthew T Method for vascular dysregulation
US20060211710A1 (en) * 2005-03-17 2006-09-21 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US8338441B2 (en) * 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
PL331507A1 (en) 1999-08-30
IL128531A0 (en) 2000-01-31
ID23218A (id) 2000-03-30
AR017723A1 (es) 2001-09-12
IS4975A (is) 1999-08-18
BG103180A (bg) 1999-09-30
AU1732999A (en) 1999-09-02
PA8467401A1 (es) 2000-09-29
SG81261A1 (en) 2001-06-19
PE20000266A1 (es) 2000-04-07
TR199900328A2 (xx) 1999-10-21
BR9900653A (pt) 2000-10-17
CA2262252C (en) 2006-01-10
TNSN99024A1 (fr) 2005-11-10
HRP990054A2 (en) 2000-02-29
JPH11292766A (ja) 1999-10-26
HUP9900386A2 (hu) 1999-11-29
AP9901464A0 (en) 1999-03-31
NO990722L (no) 1999-08-18
ZA991220B (en) 2000-08-16
NO990722D0 (no) 1999-02-16
CA2262252A1 (en) 1999-08-17
HU9900386D0 (en) 1999-04-28
KR19990072616A (ko) 1999-09-27
EA199900124A2 (ru) 1999-08-26
EA199900124A3 (ru) 1999-12-29
US6043260A (en) 2000-03-28
EP0951906A1 (en) 1999-10-27
MA26608A1 (fr) 2004-12-20
HUP9900386A3 (en) 1999-12-28
CN1231176A (zh) 1999-10-13
GT199900015A (es) 2000-07-26

Similar Documents

Publication Publication Date Title
OA10976A (en) Pharmaceutical compositions of corticotropin releasing hormone antagonists
EP0233461B2 (en) 4,5,6-Substituted-2-pyrimidinamines
TWI458719B (zh) 非核苷反轉錄酶抑制劑
EP1399423B1 (de) Anthranilsäureamide mit heteroarylsulfonyl-seitenkette und ihre verwendung als antiarrhythmische wirkstoffe
JPS62281858A (ja) ピペリジン誘導体及びその類縁誘導体
DE60313350T2 (de) Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
KR100817443B1 (ko) 비 효소성 당화를 예방하고 당화 관련 병변의 치료에사용될 수 있는 알부민 결합 화합물
WO2006042638A1 (de) 3,6-substituierte 5-arylamino-1h-pyidin-2-on derivative und verwandte verbindungen als poly(adp-ribose)polymerase (parp) inhibitoren zur behandlung von durch nekose oder apoptose verursachten gewebeschäden oder erkankungen
US20120309786A1 (en) 3-amino-pyridine derivatives for the treatment of metabolic disorders
TWI435871B (zh) 苯基咪唑化合物
JP2010522168A (ja) 鉱質コルチコイドレセプターモジュレータ
TW445251B (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
JPH0699309B2 (ja) 離脱症候群関連障害治療用医薬製品
DE60221152T2 (de) Diaryl-1,2,4-triazolderivate als hochselektive cyclooxygenase-2-inhibitoren
US5534532A (en) Aliphatic amino bis-aryl squalene synthase inhibitors
JPH072737B2 (ja) ５−リポキシゲナ−ゼ経路の抑制
WO2007085203A1 (fr) Nouveaux composés azahétérocycliques pentabasiques et utilisation de ces derniers dans le traitement de maladies liées au vieillissement des protéines
CZ51399A3 (cs) Farmaceutická kompozice a kit
JP2002155060A (ja) イミダゾール化合物及びその用途
KR101128372B1 (ko) 1ｈ-피리딘-2-온 유도체
KR101137168B1 (ko) 피롤로［２,３-ｄ］피리다진 유도체 및 그의 제조방법
JPS635082A (ja) ベンズイミダゾ−ル、その製法および胃酸分泌抑制剤としての処方物
JPH0770083A (ja) イミダゾール誘導体を有効成分とする血圧降下剤
JPH02142797A (ja) チアゾロトリアゾール化合物
WO2002002553A1 (en) Pharmaceutical compositions for treatment of diabetic nephropathy